LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 12 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,349,000 | -7.5% | 2,000,000 | 0.0% | 0.58% | -14.5% |
| Q4 2018 | $3,619,000 | -50.6% | 2,000,000 | 0.0% | 0.68% | -51.6% |
| Q3 2018 | $7,326,000 | -33.4% | 2,000,000 | -50.0% | 1.40% | -40.2% |
| Q2 2018 | $11,007,000 | +25.7% | 4,000,000 | 0.0% | 2.34% | +14.2% |
| Q1 2018 | $8,758,000 | +19.7% | 4,000,000 | 0.0% | 2.05% | +13.5% |
| Q4 2017 | $7,314,000 | -0.1% | 4,000,000 | 0.0% | 1.80% | -27.6% |
| Q3 2017 | $7,320,000 | – | 4,000,000 | – | 2.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RAVEN ROCK CAPITAL MANAGEMENT, LLC | 2,500,000 | $2,500,000 | 6.59% |
| LINDEN ADVISORS LP | 46,415,000 | $60,063,000 | 4.13% |
| Sage Capital Management, LLC | 2,000,000 | $2,588,000 | 3.77% |
| Man Investments (CH) AG | 4,000,000 | $5,185,000 | 2.55% |
| CAMDEN ASSET MANAGEMENT L P /CA | 37,150,000 | $48,318,000 | 1.65% |
| BASSO CAPITAL MANAGEMENT, L.P. | 7,220,000 | $9,323,000 | 1.54% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $31,664,000 | 0.75% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,000,000 | $10,350,000 | 0.30% |
| Wellesley Asset Management | 3,170 | $4,141,000 | 0.24% |
| CSS LLC/IL | 2,500,000 | $3,230,000 | 0.19% |